Over jou

Anabolic Steroids: What They Are, Uses, Side Effects & Risks

Below is a complete reference that you can keep on hand for every clinical encounter in which the patient’s blood‑pressure status or its underlying causes need to be assessed, monitored, or treated.

It contains:




Section What it covers Why it matters


1 – Initial assessment (history & exam) Identifies \"white‑coat\" hypertension, secondary causes and baseline BP trend Prevents mis‑diagnosis and unnecessary treatment


2 – Home / ambulatory monitoring Provides the most reliable picture of true BP load Drives accurate risk stratification


3 – Target organ assessment Detects early target‑organ damage (TOD) Allows timely intervention to prevent progression


4 – Risk categorisation & treatment goals Links BP levels to cardiovascular risk Sets personalised, evidence‑based targets


5 – Lifestyle optimisation First‑line therapy that is cost‑effective and side‑effect free Reduces drug burden


6 – Pharmacologic strategy Stepwise algorithm with preferred agents Minimises adverse effects while achieving goals


7 – Monitoring & follow‑up Structured schedule for reassessment Ensures sustained control and early detection of issues


Each section is intentionally concise yet complete, providing a reference that can be consulted quickly in the clinical setting.



---




Section‑by‑Section Summary



1. Overview of Hypertension



Definition: Systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg.


Classification:


- Stage 1: 130–139 / 80–89 mmHg (ACC/AHA) – treat if comorbidities present.
- Stage 2: ≥140/≥90 mmHg – initiate pharmacologic therapy.




2. Risk Assessment



Baseline Tools: ASCVD risk calculator, SPRINT‑P, or local guidelines.


High‑Risk Triggers:


- Diabetes, CKD (eGFR 

Profielinformatie